Indiana’s pharmaceutical and medical device sectors, long touted as major contributors to the state’s economy, are starting to lag the nation in growth and market share and will require a focused effort to stay competitive, according to a new report.... Read More
A Nevada-based biotech company is suing Eli Lilly and Co., saying the Indianapolis-based drugmaker is refusing to pay royalties on patented technology it claims is used in Lilly’s pending new treatment for Alzheimer’s disease.... Read More
RayzeBio Inc., a San Diego-based company that is building a large factory on the northwest side of Indianapolis to make radioisotopes for cancer treatment, has agreed to be acquired by pharmaceutical company Bristol Myers Squibb for $4.1 billion.... Read More
In its latest push into artificial intelligence, Lilly has signed a deal with a California-based biotech to discover new obesity targets in humans. Fauna Bio says it will give Lilly access to its AI platform to support preclinical drug discovery efforts.... Read More
Community Health Network has agreed to pay the U.S. government $345 million to settle allegations that it engaged in a years-long scheme to recruit physicians and pay them huge salaries and bonuses in return for “downstream referrals” on medical procedures.... Read More
Suddenly, Eli Lilly and Co. has a new potential competitor in the lucrative market for obesity drugs. Roche AG, the health care giant based in Basel, Switzerland, says is acquiring a California-based biotech that is developing obesity drugs for $2.7 billion.... Read More
Electric utility AES Indiana has reached a settlement agreement that would raise monthly rates next year by approximately 7.3% for the average residential customer but would clamp down on the utility's disconnection practice and offer other consumer protections.... Read More
One of Bloomington’s largest employers is now under new ownership, following the decision by Baxter International to sell its biopharma operations to a new company backed by private-equity and investment firms.... Read More
Eli Lilly and Co. announced Friday morning it plans to build a $2.5 billion factory in Germany to make injectable drugs, its latest move to meet the soaring demand for its medicines for diabetes and weight loss.... Read More
A five-year-old company in Carmel that makes a hand-sanitizing device has filed for bankruptcy reorganization. The business makes a hand-sanitizing device called Iggy that kills pathogens with ozone-infused water instead of soap or other chemicals. ... Read More
